Pell Bio-Med Technology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	2,248	306.7	427.37	167.68	172.4	115.78
Short-Term Investments	101	351	479.75	938.15	536	-
Trading Asset Securities	-	-	29.06	-	-	-
Cash & Short-Term Investments	2,349	657.7	936.18	1,106	708.4	115.78
Cash Growth	129.00%	-29.75%	-15.34%	56.10%	511.84%	-
Accounts Receivable	6.33	5.07	3.75	7.61	6.05	4.5
Other Receivables	3.47	3.21	2.4	0.33	0.36	6.12
Receivables	9.8	8.27	6.15	7.94	6.41	10.62
Inventory	12.75	6.62	6.18	3.76	4.58	4.24
Prepaid Expenses	23.06	5.46	9.22	8.86	5.84	1.1
Other Current Assets	100.1	653.37	200	0.65	0.16	0.08
Total Current Assets	2,495	1,331	1,158	1,127	725.39	131.82
Property, Plant & Equipment	722.74	709.81	386.45	260.92	298.97	249.74
Long-Term Investments	0.27	0.27	0.37	0.37	0.26	0.26
Other Intangible Assets	3.08	2.93	1.89	2.4	2.71	1.47
Other Long-Term Assets	69.91	67.8	198.39	27.44	17.07	10.61
Total Assets	3,291	2,112	1,745	1,418	1,044	393.89
Accounts Payable	8.19	5.83	4.49	6.99	5.72	8.61
Accrued Expenses	95.16	106.49	64.12	39.74	14.58	19.19
Short-Term Debt	100	100	200	-	5	-
Current Portion of Leases	29.89	27.99	27.55	25.09	25.07	10.76
Current Unearned Revenue	-	0.02	0.02	-	-	0.75
Other Current Liabilities	26.58	68.64	25.17	17.47	6.86	4.87
Total Current Liabilities	259.82	308.97	321.35	89.3	57.24	44.18
Long-Term Leases	109.11	109.28	137.27	147.47	172.56	124.84
Other Long-Term Liabilities	0.02	0.02	-	-	-	-
Total Liabilities	368.95	418.27	458.62	236.77	229.79	169.02
Common Stock	649.13	587.98	578.43	539.43	443.65	333.76
Additional Paid-In Capital	3,707	1,910	1,804	1,449	774.25	77.38
Retained Earnings	-1,708	-1,631	-1,207	-817.85	-419.09	-188.96
Treasury Stock	-0.6	-0.8	-0.8	-0.8	-	-
Comprehensive Income & Other	13.33	555.74	5.52	-	2.13	2.69
Total Common Equity	2,661	1,422	1,180	1,170	800.94	224.86
Minority Interest	261.48	272.07	106.29	11.18	13.67	0.01
Shareholders' Equity	2,922	1,694	1,286	1,181	814.6	224.87
Total Liabilities & Equity	3,291	2,112	1,745	1,418	1,044	393.89
Total Debt	239	237.27	364.82	172.56	202.63	135.6
Net Cash (Debt)	2,110	420.43	571.36	933.27	505.77	-19.82
Net Cash Growth	215.94%	-26.41%	-38.78%	84.52%	-	-
Net Cash Per Share	35.02	7.17	10.01	20.17	12.89	-0.60
Filing Date Shares Outstanding	64.79	58.72	57.8	53.9	44.36	33.28
Total Common Shares Outstanding	64.79	58.72	57.8	53.9	44.36	33.28
Working Capital	2,235	1,022	836.38	1,038	668.15	87.64
Book Value Per Share	41.06	24.22	20.41	21.71	18.05	6.76
Tangible Book Value	2,658	1,419	1,178	1,168	798.22	223.39
Tangible Book Value Per Share	41.02	24.17	20.38	21.67	17.99	6.71
Machinery	318.48	310.33	95.05	90.37	81.84	75.31
Construction In Progress	300.61	285.99	148.34	-	-	-
Leasehold Improvements	104.12	104.12	86.72	86.72	86.18	86